BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 19944126)

  • 1. Chemical risk assessment and uncertainty associated with extrapolation across exposure duration.
    Pohl HR; Chou CH; Ruiz P; Holler JS
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):18-23. PubMed ID: 19944126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health effects classification and its role in the derivation of minimal risk levels: renal effects.
    Chou CH; Pohl HR
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):202-8. PubMed ID: 15921839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilizing uncertainty factors in minimal risk levels derivation.
    Pohl HR; Abadin HG
    Regul Toxicol Pharmacol; 1995 Oct; 22(2):180-8. PubMed ID: 8577953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating toxicologic end points to derive minimal risk levels for hazardous substances.
    Chou CH; Williams M; Jones D; De Rosa CT
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):71-5. PubMed ID: 12018018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision of estimates of an ADI (or TDI or PTWI).
    Speijers GJ
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effects classification and its role in the derivation of minimal risk levels: developmental effects.
    Pohl HR; Smith-Simon C; Hicks H
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):55-60. PubMed ID: 9784433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic oral LOAEL prediction by using a commercially available computational QSAR tool.
    Rupp B; Appel KE; Gundert-Remy U
    Arch Toxicol; 2010 Sep; 84(9):681-8. PubMed ID: 20224925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Public health guidance values for chemical mixtures: current practice and future directions.
    Pohl HR; Hansen H; Chou CH
    Regul Toxicol Pharmacol; 1997 Dec; 26(3):322-9. PubMed ID: 9441922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of hematological effects in the development of minimal risk levels.
    Abadin HG; Murray HE; Wheeler JS
    Regul Toxicol Pharmacol; 1998 Aug; 28(1):61-6. PubMed ID: 9784434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health effects classification and its role in the derivation of minimal risk levels: reproductive and endocrine effects.
    Pohl HR; Luukinen B; Holler JS
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):209-17. PubMed ID: 15921838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health assessment of phosgene: approaches for derivation of reference concentration.
    Gift JS; McGaughy R; Singh DV; Sonawane B
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health effects classification and its role in the derivation of minimal risk levels: hepatic effects.
    Pohl HR; Chou CH
    Regul Toxicol Pharmacol; 2005 Jul; 42(2):161-71. PubMed ID: 15869832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The application of non-default uncertainty factors in the U.S. EPA's Integrated Risk Information System (IRIS). Part I: UF(L), UF(S), and "other uncertainty factors".
    Stedeford T; Zhao QJ; Dourson ML; Banasik M; Hsu CH
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2007; 25(3):245-79. PubMed ID: 17763048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAR/QSAR methods in public health practice.
    Demchuk E; Ruiz P; Chou S; Fowler BA
    Toxicol Appl Pharmacol; 2011 Jul; 254(2):192-7. PubMed ID: 21034766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deriving uncertainty factors for threshold chemical contaminants in drinking water.
    Ritter L; Totman C; Krishnan K; Carrier R; Vézina A; Morisset V
    J Toxicol Environ Health B Crit Rev; 2007 Oct; 10(7):527-57. PubMed ID: 17934949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the uncertainty factor for subchronic-to-chronic extrapolation: statistical analysis of toxicity data.
    Pieters MN; Kramer HJ; Slob W
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):108-11. PubMed ID: 9671565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of acute exposure guideline levels for airborne exposures to hazardous substances.
    Krewski D; Bakshi K; Garrett R; Falke E; Rusch G; Gaylor D
    Regul Toxicol Pharmacol; 2004 Apr; 39(2):184-201. PubMed ID: 15041148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical warfare agents: estimating oral reference doses.
    Opresko DM; Young RA; Faust RA; Talmage SS; Watson AP; Ross RH; Davidson KA; King J
    Rev Environ Contam Toxicol; 1998; 156():1-183. PubMed ID: 9597943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.